ACE and metabolic syndrome: Specific patient monitoring and the concomitant use of lipid-lowering agents, angiotensin-converting-enzyme inhibitors, angiotensin receptor blockers, and induction therapies should be considered for combating dyslipidemia, proteinuria, and AR (16, 59).